title: Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
abstract: OBJECTIVE
  To analyse the clinical value of procalcitonin (PCT), C-reactive protein (CRP) and leucocyte count in the diagnosis of paediatric sepsis and in the stratification of patients according to severity.
  
  
  METHODS
  Prospective, observational study.
  
  
  METHODS
  Paediatric intensive care unit (PICU).
  
  
  METHODS
  Ninety-four children.
  
  
  RESULTS
  Leucocyte count, PCT and CRP were measured when considered necessary during the PICU stay. Patients were classified, when PCT and CRP were measured, into one of six categories (negative, SIRS, localized infection, sepsis, severe sepsis, and septic shock) according to the definitions of the American College of Chest Physicians /Society of Critical Care Medicine. A total of 359 patient day episodes were obtained. Leucocyte count did not differ across the six diagnostic classes considered. Median plasma PCT concentrations were 0.17, 0.43, 0.79, 1.80, 15.40 and 19.13 ng/ml in negative, systemic inflammatory response syndrome (SIRS), localized infection, sepsis, severe sepsis, and septic shock groups, respectively, whereas median plasma CRP concentrations were 1.35, 3.80, 6.45, 5.70, 7.60 and 16.2 mg/dl, respectively. The area under the ROC curve for the diagnosis of septic patients was 0.532 for leucocyte count (95% CI, 0.462-0.602), 0.750 for CRP (95% CI, 0.699-0.802) and 0.912 for PCT (95% CI, 0.882-0.943). We obtained four groups using CRP values and five groups using PCT values that classified a significant percentage of patients according to the severity of the different SIRS groups.
  
  
  CONCLUSIONS
  PCT is a better diagnostic marker of sepsis in critically ill children than CRP. The CRP, and especially PCT, may become a helpful clinical tool to stratify patients with SIRS according to disease severity.
authors.affiliation: Department of Paediatrics, Paediatric Intensive Care Unit, Hospital Universitario Central de Asturias, University of Oviedo, Celestino Villamil s/n., 33006, Oviedo, Spain. crey@uniovi.es
authors.forename: Corsino
authors.initials: C
authors.lastname: Rey
authors.forename: Marta
authors.initials: M
authors.lastname: Los Arcos
authors.forename: Andrés
authors.initials: A
authors.lastname: Concha
authors.forename: Alberto
authors.initials: A
authors.lastname: Medina
authors.forename: Soledad
authors.initials: S
authors.lastname: Prieto
authors.forename: Pablo
authors.initials: P
authors.lastname: Martinez
authors.forename: Belen
authors.initials: B
authors.lastname: Prieto
mesh_terms: D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D015278:Intensive Care Units, Pediatric; D007958:Leukocyte Count; D011446:Prospective Studies; D011498:Protein Precursors / Q000097:blood*; D012372:ROC Curve; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000175:diagnosis*
chemical_list: D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D002097:C-Reactive Protein; D015740:Calcitonin Gene-Related Peptide